This platform focuses on research and development of functionalised metal nanoparticle systems for therapeutics and targeted drug delivery.
The diagnostic platform focuses on the design and development of rapid diagnostic tests for human and animal diseases and labelling reagents for in vivo imaging.
Testing of nanomaterial toxicity on various cell lines for first line exposure assessment and drug efficacy.
The production of peptides and peptoids for use in medical device fabrication and cosmetics.
Various equipment and infrastructure available for production and testing.
Meet the NIC Biolabels Team headed by Dr. Amanda Skepu.